Screener
Aspen Aerogels ASPN Total Current Liabilities
Total Current Liabilities at other companies
Other financials
Where this comes from
Reported directly by Aspen Aerogels in its filing.
Tagged under the XBRL concept us-gaap:LiabilitiesCurrent.
The source filing: Aspen Aerogels’s 10-Q, filed August 7, 2026.
- Filed
- Aug 7, 2026, 4:15 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-340275
| Line item | June 30, 2026 | December 31, 2025 |
|---|---|---|
| Operating lease liabilities | 2,947 | 3,245 |
| Finance lease liabilities | 1,860 | 1,768 |
| Long term debt - current portion | 23,346 | 25,115 |
| Total current liabilities | 98,649 | 62,025 |
| Revolving line of credit | 10,880 | 14,346 |
| Long term debt | 56,975 | 65,455 |
| Deferred revenue long-term | 9,738 | — |
| Finance obligation for sale and leaseback transactions long-term | 2,391 | 4,953 |
Item 1. Financial Statements.
FAQ
- What is Aspen Aerogels's total current liabilities?
- Aspen Aerogels (ASPN) reported total current liabilities of $98.65M in Q2 2026.
- How has Aspen Aerogels's total current liabilities changed year-over-year?
- Aspen Aerogels's total current liabilities increased by 26.4% year-over-year, from $78.05M to $98.65M.
- What is the long-term trend for Aspen Aerogels's total current liabilities?
- Over 5 years (2020 to 2025), Aspen Aerogels's total current liabilities has grown at a 34.8% compound annual growth rate (CAGR), from $13.93M to $62.03M.
- What does total current liabilities mean?
- The sum of all obligations due within one year — payables, accrued expenses, current debt, deferred revenue, and other short-term liabilities.
Ask your AI about Aspen Aerogels's total current liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude